Takenori Haruna
Overview
Explore the profile of Takenori Haruna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanai K, Oka A, Kariya S, Fujiwara T, Higaki T, Makihara S, et al.
Allergol Int
. 2024 Feb;
73(3):477-480.
PMID: 38307820
No abstract available.
2.
Haruna T, Kariya S, Higaki T, Murai A, Kanai K, Oka A, et al.
Auris Nasus Larynx
. 2022 Jun;
50(1):81-86.
PMID: 35768286
Objective: Combination intranasal drugs with a corticosteroid and antihistamine are available in several countries with better effect than treatments with single agents. However, it remains unclear whether this effect is...
3.
Kumanomidou H, Kanai K, Oka A, Haruna T, Hirata Y, Makihara S, et al.
Allergol Int
. 2021 Dec;
71(2):207-213.
PMID: 34872827
Background: The total naso-ocular symptom score (TSS) is widely used as an endpoint to evaluate the severity of seasonal allergic rhinitis. However, it is not a generic preference-based measure. We...
4.
Oka A, Kidoguchi M, Kariya S, Fujiwara T, Yuta A, Miyashita H, et al.
Allergy
. 2021 Apr;
76(8):2617-2620.
PMID: 33864682
No abstract available.
5.
Kidoguchi M, Yoshida K, Noguchi E, Nakamura T, Morii W, Haruna T, et al.
Allergol Int
. 2020 Jul;
69(4):619-621.
PMID: 32605765
No abstract available.
6.
Hirata Y, Kariya S, Kanai K, Fujiwara T, Makihara S, Omichi R, et al.
Am J Rhinol Allergy
. 2020 Jun;
35(1):44-51.
PMID: 32551924
Background: Hyaluronan is one of the major extracellular matrixes in chronic rhinosinusitis (CRS) associated with tissue remodeling. Prostaglandin D (PGD) is also associated with the pathogenesis of CRS. However, little...
7.
Oka A, Ninomiya T, Fujiwara T, Takao S, Sato Y, Gion Y, et al.
Allergol Int
. 2020 Jan;
69(3):417-423.
PMID: 31952913
Background: Type 2 chronic rhinosinusitis (CRS), especially eosinophilic CRS (ECRS), is an intractable upper airway inflammatory disease. Establishment of serum biomarkers reflecting the pathophysiology of CRS is desirable in a...
8.
Kanai K, Okano M, Fujiwara T, Kariya S, Haruna T, Omichi R, et al.
Allergol Int
. 2019 Dec;
69(1):163.
PMID: 31839509
No abstract available.
9.
Tachibana T, Kariya S, Orita Y, Makino T, Haruna T, Matsuyama Y, et al.
Acta Otolaryngol
. 2019 Jul;
139(9):788-792.
PMID: 31271329
Although there are studies regarding the efficacy of OK-432 sclerotherapy on thyroglossal duct cyst (TDC), its effects on surgical procedure following this therapy have not been properly described. The present...
10.
Tachibana T, Kariya S, Orita Y, Makino T, Haruna T, Matsuyama Y, et al.
Acta Otolaryngol
. 2019 Apr;
139(6):487-491.
PMID: 30957610
Background: Traumatic tympanic membrane perforation (TTMP) is usually managed conservatively because most close spontaneously within a few months. Nevertheless, spontaneous closure of TTMP during long-term observation has not been well...